3:30
Genetic Testing And Risk Stratification In Fatty Liver Disease – Dr. Christopher Kasia
MD Newsline
3:01
Why Obesity and Diabetes Drive MASLD and MASH in Youth – Dr. Christopher Kasia
3:56
Why Clinical Trials Matter For MASLD And MASH Patients – Dr. Christopher Kasia
3:29
Medication Side Effects And Personalized Care In MASLD And MASH – Dr. Christopher Kasia
3:03
Cross Specialty Collaboration And New Treatments In MASLD And MASH – Dr. Christopher Kasia
3:26
Managing Compensated Cirrhosis And Transplant Evaluation In MASLD – Dr. Christopher Kasia
3:50
Risk Stratification And FibroScan Use In MASLD And MASH – Dr. Christopher Kasia
3:35
Patient Profiles, Comorbidities, And Cardiovascular Risk In MASLD And MASH – Dr. Christopher Kasia
